Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Sasamura

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Hypertension (Dallas, Tex. : 1979)|December 3, 2008
"Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertensionKimiko Ishiguro, Kaori Hayashi, Hiroyuki Sasamura, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 6, 2006
Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertensionHiroyuki Sasamura, Yudai Kitamura, Mari Nakamura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 27, 2007
Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injuryKimiko Ishiguro, Hiroyuki Sasamura, Yusuke Sakamaki, et al.
FEBS Letters|April 6, 2004
Functional characterization of podocan, a member of a new class in the small leucine-rich repeat protein familyRyoko Shimizu-Hirota, Hiroyuki Sasamura, Mari Kuroda, et al.
Kidney International|April 9, 2010
Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2Kaori Hayashi, Hiroyuki Sasamura, Kimiko Ishiguro, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 13, 2009
Prevention and regression of hypertension: role of renal microvascular protectionHiroyuki Sasamura, Kaori Hayashi, Kimiko Ishiguro, et al.
Nephron. Experimental Nephrology|May 29, 2008
Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathyKimiko Ishiguro, Hiroyuki Sasamura, Yusuke Sakamaki, et al.
Circulation Research|March 20, 2004
Extracellular matrix glycoprotein biglycan enhances vascular smooth muscle cell proliferation and migrationRyoko Shimizu-Hirota, Hiroyuki Sasamura, Mari Kuroda, et al.
The Journal of Clinical Investigation|May 10, 2014
KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuriaKaori Hayashi, Hiroyuki Sasamura, Mari Nakamura, et al.
Endocrine Journal|November 2, 2004
Use of gadolinium contrast adrenal venography for the assessment of primary aldosteronism in a patient with iodine allergyHiroyuki Sasamura, Subaru Hashimoto, Sachio Kuribayashi, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Hypertension (Dallas, Tex. : 1979)|December 3, 2008
"Pulse" treatment with high-dose angiotensin blocker reverses renal arteriolar hypertrophy and regresses hypertensionKimiko Ishiguro, Kaori Hayashi, Hiroyuki Sasamura, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 6, 2006
Effects of the angiotensin receptor blocker candesartan on arterial stiffness and markers of extracellular matrix metabolism in patients with essential hypertensionHiroyuki Sasamura, Yudai Kitamura, Mari Nakamura, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 27, 2007
Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injuryKimiko Ishiguro, Hiroyuki Sasamura, Yusuke Sakamaki, et al.
FEBS Letters|April 6, 2004
Functional characterization of podocan, a member of a new class in the small leucine-rich repeat protein familyRyoko Shimizu-Hirota, Hiroyuki Sasamura, Mari Kuroda, et al.
Kidney International|April 9, 2010
Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2Kaori Hayashi, Hiroyuki Sasamura, Kimiko Ishiguro, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|June 13, 2009
Prevention and regression of hypertension: role of renal microvascular protectionHiroyuki Sasamura, Kaori Hayashi, Kimiko Ishiguro, et al.
Nephron. Experimental Nephrology|May 29, 2008
Differential effects of transient treatment of spontaneously hypertensive rats with various antihypertensive agents on the subsequent development of diabetic nephropathyKimiko Ishiguro, Hiroyuki Sasamura, Yusuke Sakamaki, et al.
Circulation Research|March 20, 2004
Extracellular matrix glycoprotein biglycan enhances vascular smooth muscle cell proliferation and migrationRyoko Shimizu-Hirota, Hiroyuki Sasamura, Mari Kuroda, et al.
The Journal of Clinical Investigation|May 10, 2014
KLF4-dependent epigenetic remodeling modulates podocyte phenotypes and attenuates proteinuriaKaori Hayashi, Hiroyuki Sasamura, Mari Nakamura, et al.
Endocrine Journal|November 2, 2004
Use of gadolinium contrast adrenal venography for the assessment of primary aldosteronism in a patient with iodine allergyHiroyuki Sasamura, Subaru Hashimoto, Sachio Kuribayashi, et al.
Pageof 4